Lyra Therapeutics, Inc. (LYRA) financial statements (2022 and earlier)

Company profile

Business Address 480 ARSENAL STREET
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45,74774,593
Cash and cash equivalents45,74774,593
Other undisclosed current assets2,1711,324
Total current assets:47,91875,917
Noncurrent Assets
Operating lease, right-of-use asset1,3552,301
Property, plant and equipment4,5032,165
Restricted cash and investments329329
Other noncurrent assets762118
Total noncurrent assets:6,9494,913
TOTAL ASSETS:54,86780,830
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,0403,369
Accounts payable3,125922
Accrued liabilities486555
Employee-related liabilities2,4291,892
Deferred revenue9,789 
Other liabilities147149
Other undisclosed current liabilities2,2701,366
Total current liabilities:18,2464,884
Noncurrent Liabilities
Long-term debt and lease obligation3791,454
Operating lease, liability3791,454
Liabilities, other than long-term debt1,926 
Deferred revenue1,926 
Other undisclosed noncurrent liabilities (1,454)
Total noncurrent liabilities:2,3051,454
Total liabilities:20,5516,338
Stockholders' equity
Stockholders' equity attributable to parent34,31674,492
Common stock1313
Additional paid in capital227,700224,363
Accumulated deficit(193,397)(149,884)
Total stockholders' equity:34,31674,492
TOTAL LIABILITIES AND EQUITY:54,86780,830

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Revenues285 
Gross profit:285 
Operating expenses(43,900)(22,209)
Operating loss:(43,615)(22,209)
Nonoperating income
(Investment Income, Nonoperating)
10282
Net loss attributable to parent:(43,513)(22,127)
Preferred stock dividends and other adjustments (115)
Net loss available to common stockholders, diluted:(43,513)(22,242)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(43,513)(22,127)
Comprehensive loss, net of tax, attributable to parent:(43,513)(22,127)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: